News New auction for 23andMe sought with $305m bid from ex-CEO A new auction for bankrupt genetic testing company 23andMe looks likely after former CEO Anne Wojcicki offered to outbid Regeneron.
News Regeneron swoops on genetic testing firm 23andMe DNA testing company 23andMe looks destined to be taken over by a pharma company, as Regeneron agrees a $256 million acquisition deal.
Partner Content Partner Content Workshop speakers Laurent Dolle, BWB and Mary-Beth Joshi ann... Workshop speakers Laurent Dolle, BWB and Mary-Beth Josh
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
